News
1d
AllAfrica on MSNSouth Africa: Missed, Misunderstood, and Deadly - a Cape Town Family's Heartbreak With Hepatitis BWhen Desmond Pedro discovered a strange hardness under his ribcage, he was just 30 and preparing for a fresh start on a government skills course. Little did he know that he would soon die of liver ...
As Hepatitis B is widely misunderstood and insufficiently screened, Asian Americans are disproportionately affected.
Patients with untreated chronic hepatitis B and metabolic comorbidities face a higher risk for advanced liver fibrosis and ...
13d
What to Expect on MSNShould You Eat Your Placenta? Why Some Moms Swear by It and What the Experts SayProponents of eating the placenta say the practice has benefits — but there are risks, too. Here's what you need to know.
Hepatitis B is a liver infection that inflames the organ and impacts its ability to function. It can be either acute (short-term) or chronic (long-term), and is estimated to impact between 880,000 ...
If you're also taking ribavirin (Rebetol, Virazole), you could have joint pain, anemia, or feel depressed. Let your doctor know if you've had hepatitis B before you start this drug. It could make ...
and hepatitis B from a blood transfusion is one per 2.3 million, 2.6 million, and 1.5 million donations, respectively. The treatment is usually watchful waiting for those who experience mild anemia ...
hypocalcemia and normocytic normochromic anemia. Hepatitis B virus infection was confirmed in our patients based on positive HBsAg serology (ELISA method). Cirrhosis was defined by a more or less ...
A new study published in the journal of Nature Scientific Reports found that anemia was almost three times as common in women with a persistent hepatitis B virus (HBV) infection. Around 50% of ...
The hepatitis B vaccine protects against liver infection caused by the hepatitis B virus (HBV). This virus is highly contagious and can spread through exposure to blood, semen, and other bodily ...
Demonstrated durable hematologic response across all patient subgroups, regardless of baseline transfusion status and concomitant JAK inhibitor therapy Phase 2 study in MF anemia has been initiated, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results